KL, klotho, 9365

N. diseases: 332; N. variants: 20
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL
0.540 Biomarker disease BEFREE Inactivating autosomal recessive mutations in fibroblast growth factor 23 <i>(FGF23), klotho (KL) and polypeptide N-acetylgalactosaminotransferase 3 (GALNT3)</i> genes lead to a rare disorder, hyperphosphatemic familial tumoral calcinosis (HFTC). 30015621 2019
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL
0.540 Biomarker disease BEFREE Inactivating mutations in FGF23, N-acetylgalactosaminyltransferase 3 (GALNT3), or KLOTHO (KL) have been reported as causing HFTC/HHS. 30226830 2018
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL
0.540 GeneticVariation disease BEFREE Familial tumoral calcinosis (FTC)/hyperostosis-hyperphosphatemia syndrome (HHS) is a rare disorder caused by mutations in the genes encoding fibroblast growth factor-23 (FGF23), N-acetylgalactosaminyltransferase 3 (GALNT3), or KLOTHO. 27164190 2016
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL
0.540 Biomarker disease BEFREE To date, recessive mutations have been described in three genes involving phosphate metabolism: FGF23, GALNT3, and α-Klotho, all of which result in the phenotypic presentation of hFTC. 25656441 2015
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL
0.540 Biomarker disease MGD N-ethyl-N-Nitrosourea (ENU) induced mutations within the klotho gene lead to ectopic calcification and reduced lifespan in mouse models. 25860694 2015
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL
0.540 GermlineCausalMutation disease ORPHANET Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho). 22142751 2011
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL
0.540 GermlineCausalMutation disease ORPHANET A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. 17710231 2007